Fredrick M. Wigley

24.2k citations

222 papers · 12.3k indexed · 1 hit paper · h-index 62

Impact in

Pathology and Forensic Medicine top 0.05%
- Systemic Sclerosis and Related Diseases
Dermatology top 0.05%
- Dermatologic Treatments and Research

Papers in

Pathology and Forensic Medicine 175
- Systemic Sclerosis and Related Diseases 172
Dermatology 56
- Dermatologic Treatments and Research 46

Co-authors: Laura K. Hummers Robert A. Wise Ami A. Shah Allan C. Gelber Antony Rosen Barbara White Livia Casciola‐Rosen Francesco Boin
Journals: Arthritis Care & Research (14 papers)The American Journal of Medicine (11 papers)Arthritis & Rheumatology (11 papers)Lara D. Veeken (8 papers)Current Opinion in Rheumatology (7 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Fredrick M. Wigley

220 papers receiving 11.9k citations

Hit Papers

align trajectories log scale

Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis 2000 · 517 citations

Peers

Countries citing papers authored by Fredrick M. Wigley

Since Specialization

Citations

This map shows the geographic impact of Fredrick M. Wigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrick M. Wigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrick M. Wigley more than expected).

Fields of papers citing papers by Fredrick M. Wigley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrick M. Wigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrick M. Wigley. The network helps show where Fredrick M. Wigley may publish in the future.

Co-authors

The 25 scholars most cited alongside Fredrick M. Wigley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fredrick M. Wigley Line = papers co-authored together Fredrick M. Wigley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis Seminars in Arthritis and Rheumatism ·Rachel Wallwork, Jonathan J. Kotzin, Laura C. Cappelli, Christopher A. Mecoli, Clifton O. Bingham, Fredrick M. Wigley, Parker C. Wilson, Dana DiRenzo, Ami A. Shah	2024	0
2	Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis Lara D. Veeken ·Carrie Richardson, Jamie Perin, Scott L. Zeger, Fredrick M. Wigley, Laura K. Hummers, Livia Casciola‐Rosen, Antony Rosen, Ami A. Shah	2022	7
3	Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma Arthritis & Rheumatology ·Eleni Tiniakou, Andrea Fava, Zsuzsanna H. McMahan, Tara Guhr, Robert N. O’Meally, Ami A. Shah, Fredrick M. Wigley, Robert N. Cole, Francesco Boin, Erika Darrah	2020	12
4	Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis Science Translational Medicine ·Joseph Shin, James D. Beckett, Rustam Bagirzadeh, Tyler J. Creamer, Ami A. Shah, Zsuzsanna H. McMahan, Julie J. Paik, Margaret Sampedro, Elena Gallo MacFarlane, M Beer, Daniel Warren, Fredrick M. Wigley, Harry C. Dietz	2019	50
5	Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study Arthritis Care & Research ·Kira E. Riehm, Linda Kwakkenbos, Marie‐Eve Carrier, Susan J. Bartlett, Vanessa L. Malcarne, Luc Mouthon, Warren R. Nielson, Serge Poiraudeau, Karen Nielsen, Murray Baron, Tracy Frech, Marie Hudson, Janet Pope, Maureen Sauvé, María E. Suarez‐Almazor, Fredrick M. Wigley, Brett D. Thombs	2015	29
6	Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension Circulation Heart Failure ·Ryan J. Tedford, James O. Mudd, Reda E. Girgis, Stephen C. Mathai, Ari Zaiman, Traci Housten-Harris, Danielle Boyce, Benjamin W. Kelemen, Anita C. Bacher, Ami A. Shah, Laura K. Hummers, Fredrick M. Wigley, Stuart D. Russell, Rajeev Saggar, Rajan Saggar, W L Maughan, Paul M. Hassoun, David A. Kass	2013	182
7	Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer Science ·Christine Joseph, Erika Darrah, Ami A. Shah, Andrew D. Skora, Livia Casciola‐Rosen, Fredrick M. Wigley, Francesco Boin, Andrea Fava, Christopher J. Thoburn, Isaac Kinde, Yuchen Jiao, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Antony Rosen	2013	300
8	A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon Annals of the Rheumatic Diseases ·Laura K. Hummers, Carin E. Dugowson, Frederick J. Dechow, Robert A. Wise, Jeffrey Gregory, Joel Michalek, Gayane Yenokyan, John McGready, Fredrick M. Wigley	2012	26
9	The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis Lara D. Veeken ·Ruby Knafo, Jennifer A. Haythornthwaite, Leslie J. Heinberg, Fredrick M. Wigley, Brett D. Thombs	2011	22
10	Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease The Open Rheumatology Journal ·Shikha Mittoo, Fredrick M. Wigley, Robert A. Wise, Adrianne Woods, Hui-Qing Xiao, Laura K. Hummers	2011	10
11	Development and validation of the brief‐satisfaction with appearance scale for systemic sclerosis Arthritis Care & Research ·Lisa R. Jewett, Marie Hudson, Jennifer A. Haythornthwaite, Leslie J. Heinberg, Fredrick M. Wigley, Murray Baron, Brett D. Thombs	2010	34
12	“Still” Ill? The American Journal of Medicine ·Peter K. Wung, Matthew R. Pipeling, Fredrick M. Wigley	2008	1
13	Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review Current Opinion in Rheumatology ·Sheridan Henness, Fredrick M. Wigley	2007	31
14	Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients Arthritis & Rheumatism ·Irina G. Luzina, Sergei P. Atamas, Robert A. Wise, Fredrick M. Wigley, Jin‐Ho Choi, Hui Xiao, Barbara White	2003	95
15	Recombinant Human Relaxin in the Treatment of Scleroderma Annals of Internal Medicine ·James R. Seibold, Joseph H. Korn, Robert W. Simms, Phillip J. Clements, Larry W. Moreland, Maureen D. Mayes, Daniel E. Fürst, Naomi F. Rothfield, Virginia Steen, Michael Weisman, David H. Collier, Fredrick M. Wigley, Peter A. Merkel, Mary Ellen Csuka, Vivien Hsu, Susan Rocco, Mark Erikson, John H. Hannigan, W. Scott Harkonen, Martin E. Sanders	2000	44
16	High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial Arthritis & Rheumatism ·Philip J. Clements, Daniel E. Fürst, Weng Kee Wong, Maureen D. Mayes, Barbara White, Fredrick M. Wigley, Michael H. Weisman, Walter G. Barr, Larry W. Moreland, Thomas A. Medsger, Virginia Steen, Richard W. Martin, David H. Collier, Arthur Weinstein, Edward V. Lally, John Varga, Steven Weiner, Brian S. Andrews, Micha Abeles, James R. Seibold	1999	210
17	African-American Race and Antibodies to Topoisomerase I Are Associated With Increased Severity of Scleroderma Lung Disease CHEST Journal ·Eric L. Greidinger, Keith T. Flaherty, Barbara White, Antony Rosen, Fredrick M. Wigley, Robert A. Wise	1998	102
18	Treatment of scleroderma Current Opinion in Rheumatology ·Allan C. Gelber, Fredrick M. Wigley	1995	7
19	Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma. PubMed ·Daniel O. Clegg, James C. Reading, Maureen D. Mayes, James R. Seibold, Cheryl P. Harris, Fredrick M. Wigley, John Ward, Edward J. Pisko, Michael H. Weisman, P. Lee, Larry W. Moreland, Rosemarie Neuner, Eric P. Gall, Philip J. Clements, Jason Spindler, Edward V. Lally	1994	13
20	HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis The American Journal of Medicine ·Thomas E. Scott, Robert A. Wise, Marc C. Hochberg, Fredrick M. Wigley	1987	23

About Fredrick M. Wigley

Fredrick M. Wigley is a scholar working on Pathology and Forensic Medicine, Dermatology, Rheumatology, Pulmonary and Respiratory Medicine and Immunology, having authored 222 papers that have together received 12.3k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (172 papers), Dermatologic Treatments and Research (46 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (41 papers), Inflammatory Myopathies and Dermatomyositis (38 papers), Pulmonary Hypertension Research and Treatments (33 papers), Mast cells and histamine (31 papers), Connective Tissue Growth Factor Research (21 papers) and Eosinophilic Disorders and Syndromes (19 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.0k citations), Dermatology (2.5k citations), Rheumatology (2.7k citations), Pulmonary and Respiratory Medicine (4.0k citations) and Immunology (1.9k citations). Fredrick M. Wigley has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Laura K. Hummers, Robert A. Wise, Ami A. Shah, Allan C. Gelber, Antony Rosen, Barbara White, Livia Casciola‐Rosen, Francesco Boin, Stephen C. Mathai and Paul M. Hassoun. Their work appears in journals such as Arthritis Care & Research, The American Journal of Medicine, Arthritis & Rheumatology, Lara D. Veeken and Current Opinion in Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact